摘要
Abstract: In regenerative medicine, biomaterial-based medication delivery systems are a gamechanger because they allow for the restoration of function and the healing of damaged tissues. This study aims to examine the potential of synthetic and natural biomaterials for the delivery of medications and the regeneration of tissues. Our mission is to highlight the most recent developments in manufacturing techniques, drug delivery systems, and biomaterial design that have enhanced therapeutic benefits. Techniques such as stimuli-responsive carriers, targeted delivery methods, and diffusioncontrolled systems make use of biomaterials including chitosan, PLGA, and collagen. A comprehensive literature evaluation was conducted using search terms such as "biomaterials AND drug delivery" and "regenerative medicine AND nanotechnology" in PubMed, Scopus, and Web of Science. Microfabrication, lithography, and three-dimensional printing were some of the fabrication techniques covered in the included research. Their versatility has led to their application in the regeneration of many tissues, including skin, cartilage, bone, and nerves. Notable findings have shown that biomaterials can improve therapeutic efficacy by meeting challenges such as biocompatibility, immunogenicity, and stability. This is achieved by controlled drug release and targeted distribution. Biomaterials show great promise for improving tissue regeneration and medication delivery targeting, according to the research. Their treatments are more efficient, have fewer side effects, and promote faster recovery. However, future studies should focus on resolving some difficulties, such as immunological response, material stability, and clinical translation. The field of biomaterial science is having an impact on the future of regenerative medicine with innovations like injectable systems and smart biomaterials. Improved patient outcomes are largely attributable to biomaterials, and recent advances in gene therapy and precision biomaterials point to a future when personalized healthcare solutions are the norm. Research in the future should focus on finding new applications and removing current limitations so that their full therapeutic potential may be realized.